World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
63
Citations
16294
World Ranking
8325
National Ranking
473

Malcolm F. G. Stevens publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Malcolm F. G. Stevens sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 370 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Malcolm F. G. Stevens D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Malcolm F. G. Stevens sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 63 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2009 - Fellow of the Royal Society, United Kingdom
  • 1991 - Interdisciplinary Prize, Royal Society of Chemistry (UK)

Overview

Malcolm F. G. Stevens is affiliated with the University of Nottingham in the United Kingdom. Their research primarily focuses on materials science with a significant concentration in materials chemistry.

The scientist has contributed notably to the study of crystallization and solubility, particularly using X-ray diffraction techniques in crystallography. Their work also interfaces with biomedical fields including glioma diagnosis and treatment, cancer therapeutics and mechanisms, and brain metastases management. Additionally, they have contributed research related to advanced biosensing and bioanalysis techniques as well as RNA interference and gene delivery.

Key recent publications include:

  • Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage, 2020, ACS Applied Materials & Interfaces
  • Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue, 2021, ACS Applied Materials & Interfaces
  • Discovery of new imidazotetrazinones with potential to overcome tumor resistance, 2023, European Journal of Medicinal Chemistry
  • Antitumour imidazotetrazines: past, present... and future?, 2023, RSC Chemical Biology
  • Modulation of the acidity of the 8-carboxamide group in the temozolomide family of antitumor imidazo[5,1-d][1,2,3,5]tetrazines, 2020, ARKIVOC

Frequent co-authors in their research include:

  • Tracey D. Bradshaw
  • Helen S. Summers
  • Christopher J. Moody
  • Magdalena B. Foreiter
  • William Lewis

Their work has appeared predominantly in the following publication venues:

  • The Cambridge Structural Database
  • ACS Applied Materials & Interfaces
  • European Journal of Medicinal Chemistry
  • RSC Chemical Biology
  • ARKIVOC

Recognition for their scientific contributions includes the Fellow of the Royal Society, United Kingdom, awarded in 2009, and the Interdisciplinary Prize from the Royal Society of Chemistry (UK) received in 1991.

Best Publications

  • Temozolomide: Mechanisms of Action, Repair and Resistance

    Jihong Zhang;Malcolm F.G. Stevens;Tracey D. Bradshaw

  • Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

    E.S. Newlands;M.F.G. Stevens;S.R. Wedge;R.T. Wheelhouse

  • Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.

    Catriona G. Mortimer;Geoffrey Wells;Jean-Philippe Crochard;Erica L. Stone

  • Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.

    Ian Hutchinson;Sharon A. Jennings;B. Rao Vishnuvajjala;and Andrew D. Westwell

  • NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA

    Brian J. Denny;Richard T. Wheelhouse;Malcolm F. G. Stevens;Lincoln L. H. Tsang

  • Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.

    Dong-Fang Shi;Tracey D. Bradshaw;Samantha Wrigley;Carol J. McCall

  • Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.

    Ian Hutchinson;Mei-Sze Chua;Helen L. Browne;Valentina Trapani

  • Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).

    Stefania Aiello;Geoffrey Wells;Erica L Stone;Hachemi Kadri

  • Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug with Potential as an Alternative to Dacarbazine

    Malcolm F. G. Stevens;John A. Hickman;Simon P. Langdon;David Chubb

  • Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

    S.M. O'Reilly;E.S. Newlands;M. Brampton;M.G. Glaser

  • Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

    N M Bleehen;E S Newlands;Siow Ming Lee;Nick Thatcher

  • Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.

    Sharon M. Gowan;Robert Heald;Malcolm F. G. Stevens;Lloyd R. Kelland

  • Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.

    Malcolm F. G. Stevens;John A. Hickman;Robert Stone;Neil W. Gibson

  • Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway.

    Angela Rizzo;Erica Salvati;Manuela Porru;Carmen D’Angelo

  • Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

    Evripidis Gavathiotis;Robert A. Heald;Malcolm F.G. Stevens;Mark S. Searle

  • Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.

    Carlo Leonetti;Sarah Amodei;Carmen D'Angelo;Angela Rizzo

  • Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues.

    Ian Hutchinson;Tracey D Bradshaw;Charles S Matthews;Malcolm F.G Stevens

  • Semisynthesis and in vitro anticancer activities of andrographolide analogues.

    Srinivasa Rao Jada;Genevieve Suseno Subur;Charlie Matthews;Ahmad Sazali Hamzah

  • Antitumor Benzothiazoles. 7. Synthesis of 2-(4-Acylaminophenyl)benzothiazoles and Investigations into the Role of Acetylation in the Antitumor Activities of the Parent Amines

    † Mei-Sze Chua;† Dong-Fang Shi;Samantha Wrigley;Tracey D. Bradshaw

  • Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.

    A. S. Clark;B. Deans;M. F. G. Stevens;M. J. Tisdale

  • Antitumor Polycyclic Acridines. 8.1 Synthesis and Telomerase-Inhibitory Activity of Methylated Pentacyclic Acridinium Salts

    Robert A. Heald;Chetna Modi;Jenny C. Cookson;Ian Hutchinson

  • Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

    Mei-Sze Chua;Eiji Kashiyama;Tracey D. Bradshaw;Sherman F. Stinson

Frequent Co-Authors

Charles A. Laughton
Charles A. Laughton University of Nottingham
Maurizio D'Incalci
Maurizio D'Incalci Humanitas University
Simon P. Langdon
Simon P. Langdon University of Edinburgh
Gabriella Zupi
Gabriella Zupi École Normale Supérieure de Lyon
Christopher J. Moody
Christopher J. Moody University of Nottingham
John A. Hickman
John A. Hickman University of Manchester
Mark S. Searle
Mark S. Searle University of Nottingham
Eric Gilson
Eric Gilson Université Côte d'Azur
William Lewis
William Lewis University of Sydney
Peter A. Lambert
Peter A. Lambert Aston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse online degrees and promising career paths. For students interested in healthcare, exploring how much does it cost to become a pharmacist offers valuable insights into the financial commitments and training required for this in-demand profession.

For those fascinated by forensic science, reputable programs highlight the best online colleges for forensic science, enabling students to study remotely while preparing for critical roles in criminal investigations.

Additionally, individuals curious about medical investigations can learn the steps involved in becoming a medical examiner assistant by reviewing how to become a medical examiner assistant. This career pathway combines biology and chemistry knowledge to assist in vital post-mortem analyses.

For advanced specialization, pursuing an online master’s degree in forensic psychology offers an interdisciplinary approach that intersects chemistry with psychological science, expanding career opportunities in both forensic and clinical settings.

Best Scientists Citing Malcolm F. G. Stevens

Trending Scientists